James Graham: CEO of Recce Pharmaceuticals

Portrait of James Graham

James Graham, CEO of Recce Pharmaceuticals, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Recce is working to develop a new class of synthetic anti-infectives designed to address the threat of antibiotic-resistant superbugs.

Danbury Hospital Annual Report Cover
Danbury Hospital

A Prescription for the Future

Chemtura Brochure Cover
Chemtura Corporation

The Future Through Chemistry

Bioasis Technologies

One in Six